Need more insight?
Speak to us about commissioning some bespoke research.
Find out moreHuman API is a real-time health data network enabling users to securely share and access information from thousands of clinics, labs, pharmacies, devices, and apps. The Human API platform empowers consumers to seamlessly share their health data with the developers and enterprises who provide them with better care. Today, the venture's platform powers more than 10,000 applications in 40 countries with data-driven, consumer-centric healthcare.
Established in 2013, its data network of 230m+ US consumers and 600k+ providers includes EHRs, labs, pharmacies, wearable devices, and mobile apps. Consumers are able to authorise the transfer of their data, which is then standardised and augmented using their patented machine learning data pipeline, HealthGraph. By using the Human API platform, enterprises can access rich clinical data to deliver a superior experience for their customers, users, members, and patients.
The company’s platform includes a list of data sources to retrieve data; Human Connect, a single sign-on to authenticate users' health data from various sources; Data API, a unified normalised API to manage users' health data; and a developer portal to manage users, data, and connections. Human API enables users to connect with top wearable devices, health trackers, wireless scales, and fitness and nutrition applications. The company’s solution is used by telemedicine companies, disease management platforms, consumer health applications, wellness companies, and traditional medical facilities.
Led by founder Andrei Pop, Human API's partner network includes BlueRun Ventures, Andreessen Horowitz, and SciFi VC.
In 2017, the company joined forces with LexisNexis to help life insurers lower their underwriting costs, reduce cycle times and drop-out rates, and assign applicants to appropriate risk classes.
In 2019, the company announced $10M in new funding to accelerate product development and market expansion. The round includes strong support from new investors Guardian Life Insurance Company and SCOR Life and Health Ventures, as well as returning backers BlueRun Ventures and Max Levchin's SciFi VC.
In October 2020, Human API raised $20m in Series C funding, with participation from Allianz Life Ventures and SCOR Global Life, amongst others. The new funding will be used to scale new products and services and expand its health data liquidity across more industries.
In March 2023 LexisNexis Risk Solutions entered into a definitive agreement to acquire Human API. The acquisition of Human API will enable LexisNexis Risk Solutions to further its strategic aim of delivering innovative solutions while meeting the industry’s regulatory requirements and data privacy standards. Human API is backed by Allianz Life Ventures, SCOR, and others.
HumanAPI Inc. was formerly known as Stasis Health Inc.
Speak to us about commissioning some bespoke research.
Find out more